• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    L

    Levine Cancer Institute,Carolinas Healthcare System

    EST. 2010
    879论文总数
    1.2万引用总数

    论文量&引用量时间轴

    机构学者

    排序
    Saad Z. Usmani
    Saad Z. Usmani
    David H. Koch Center for Cancer Care, Memorial Sloan Kettering Cancer Center
    论文:82引用:0H-index:0
    Peter Voorhees
    Peter Voorhees
    Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health;Division of Plasma Cell Disorders, Levine Cancer Institute, Atrium Health
    论文:61引用:0H-index:0
    Kim Edward S
    Kim Edward S
    The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai
    论文:51引用:0H-index:0
    Symanowski James T
    Symanowski James T
    Department of Cancer Biostatistics, Levine Cancer Institute/Carolinas HealthCare System
    论文:50引用:0H-index:0
    Grunwald Michael R
    Grunwald Michael R
    1650 Orleans St, CRB 186 - Oncology, Baltimore, MD 21231, USA. grunwald@jhmi.edu
    论文:39引用:0H-index:0
    Declan Walsh
    Declan Walsh
    Department of Supportive Oncology, Levine Cancer Institute
    论文:33引用:0H-index:0
    Edward Copelan
    Edward Copelan
    Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute
    论文:32引用:0H-index:0
    Ghosh Nilanjan
    Ghosh Nilanjan
    Department of Hematology/Oncology and Bone Marrow Transplantation, Levine Cancer Institute
    论文:32引用:0H-index:0
    Patel Jai N
    Patel Jai N
    Carolinas HealthCare System, Levine Cancer Institute
    论文:30引用:0H-index:0

    论文(880)

    年份
    起
    –
    止
    排序
    1Methodological Considerations and Biological Context
    Mellar P. Davis
    2026Supportive Care in Cancer(2026)引用:12
    引用
    AI阅读
    加入学术空间
    2MASCC Score and Neutropenic Complications: What is the Likelihood?
    Mellar P. Davis

    The Multinational Association for Supportive Care in Cancer (MASCC) Risk Index is the most widely used tool for stratifying febrile neutropenic cancer patients as low or high risk for serious complications. Studies evaluating its discriminative performance have relied predominantly on sensitivity, specificity, receiver operating characteristic (ROC) curves, and c-statistics—metrics that are mathematically elegant but have limited direct utility in clinical decision-making at the bedside. Sensitivity and specificity data from Rivest et al. [13], the original Klastersky et al. derivation study [3], and the Zheng et al. meta-analysis [10] were used to calculate positive and negative likelihood ratios. Posttest probabilities were derived using Bayesian updating (pretest odds × LR = posttest odds), with a cohort pretest probability of complications of 35

    2026Supportive Care in Cancer(2026)引用:11
    引用
    AI阅读
    加入学术空间
    3Intensive Nursing Intervention: What is the Post Treatment Effect Size on Anxiety and Depression?
    Mellar P. Davis
    2026Supportive Care in Cancer(2026)引用:7
    引用
    AI阅读
    加入学术空间
    4Outcomes of Bispecific Antibodies after CAR T-cell Failure for Large B-cell Lymphoma: Results from the ABC Consortium.
    Megan Melody,Natalie Grover,Stephanie Franco,Jason Romancik, Matthew Cortese, Tamara K Moyo,Rahul S Bhansali,Thomas Ollila,Vaishalee Kenkre, Lindsey Fitzgerald,Brian Hess,Matt Matasar,
    2026Blood advances(2026)引用:2
    引用
    AI阅读
    加入学术空间
    5A Proposed Ethical Framework for Informed Consent in Elective Robotic Telesurgery
    Catherine H. Frenkel,Marcio Covas Moschovas, Shady Saikali,Vipul Patel

    Guidelines for informed consent (IC) in telesurgery are not well-defined. Ethical frameworks for clinic innovation generally focus on four key concerns, IC, safety/efficacy, patient vulnerability and conflicts of interest. The purpose of this paper is to review published recommendations on IC for telesurgery and create an ethics framework for elective telesurgical IC. A scoping literature review was performed using search terms Telesurg* AND (guideline OR consensus) in PubMed, Web of Science, and SCOPUS databases. Full text English language articles published by December 18, 2025 were included. Manuscripts were excluded if clinical telesurgery was not the subject or no formal recommendations were made regarding the IC process. A ethics framework for IC was developed based on relevant literature. 83 articles were reviewed and 4 relevant manuscripts were identified. An ethics framework for IC is proposed based on the available literature and can be further adapted regionally. A local and virtual interactive multi-stage consent process is suggested. A structured disclosure approach with key elements is outlined. Relevant terminology is defined, including implicit and explicit (situational, surgeon-specific and shared responsibility) disclosure elements. IC with disclosure of situational, local and remote surgeon-specific elements, and any shared accountability is the best practice standard for elective telesurgical consent. A multi-stage local and virtual interactive consent process should be offered in an opt-out fashion.

    2026Journal of Robotic Surgery(2026)引用:2
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 880 篇论文

    合作机构(100)

    埃默里大学合作论文 83
    纪念斯隆凯特琳癌症中心合作论文 80
    德克萨斯大学奥斯汀分校合作论文 64
    Atrium Health合作论文 62
    温纳贝戈医学中心合作论文 58
    莫菲特癌症中心合作论文 49
    希望之城国家医疗中心合作论文 49
    威斯康星医学院合作论文 47
    宾夕法尼亚大学合作论文 46
    丹娜—法伯癌症研究所合作论文 42

    机构统计